Bryan Garnier - Carlsberg A/S Class B (CARL B) CARLSBERG: Boringly good | BUY - TOP PICKS | DKK1220 vs. DKK1180 (+26%)

Report

Bryan Garnier

Nikolaas Faes

CARLSBERG: Boringly good | BUY - TOP PICKS | DKK1220 vs. DKK1180 (+26%)

CARLSBERG - BUY - TOP PICKS | DKK1220 vs. DKK1180 (+26%)
Boringly good

Q3 organic revenue growth of 3.1%
2019 organic operating profit guidance of 10%
Model maintenance

31/10/2019 3 EN

Underlying

Carlsberg A/S Class B

Carlsberg is engaged in the production and sale of beer and other beverages. Co.'s brewing operations are concentrated in Northern and Western Europe, Eastern Europe and Asia, while markets outside these regions are serviced through exports and production under license. Co.'s other beverages include soft drinks, water and cider. In addition to beverage activities, Co. is also engaged in real estate.

See profile

DK0010181759 Nasdaq Nordic Copenhagen Denmark

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Nikolaas Faes

Other Reports on these Companies

DnB Markets

Carlsberg (Buy, TP: DKK1075.00) - Soft Q1, but with bright spots

We consider the Q1 results slightly on the soft side (with organic volume misses across the board), albeit less so adjusted for the loss of the San Miguel contract. Despite the general weakness, there were a couple of bright spots, including positive commentary on the premium beer market in China. We reiterate our BUY and DKK1,075 target price.

Free Trial

April 29, 2025 April 29, 2025 1 EN

DnB Markets

Carlsberg (Buy, TP: DKK1075.00) - Expect flat start to 2025e

We expect Carlsberg to report a slow start to the year, mainly related to the loss of the San Miguel contract and the timing of Easter. However, we believe this should not come as a surprise, and thus expect the 2025 guidance to be maintained. At a 12-month forward P/E of c14x, we still find the stock attractive, with further upside potential from better-than-expected execution of Britvic and any improvement in China. We reiterate our BUY and DKK1,075 target price.

Free Trial

April 22, 2025 April 22, 2025 1 EN

MarketLine

Heineken N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances

Summary Marketline's Heineken N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Heineken N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organ...

EUR 299.85

April 21, 2025 April 21, 2025 1 EN

Deliveroo: strengthening growth/margin profile ahead of DoorDash deal

Post-another strong print and FY guidance upgrade, fuelled by a recovery in order growth and market share gains, we see more credibility in Deliveroo's MT targets and have increased our EBITDA and FCF estimates by 8% and 11%. PT unchanged at 180p to stick to the DoorDash offer, which we view as fai

August 8, 2025 August 8, 2025 1 EN

Damien Choplain ... (+2)

Damien Choplain
Oscar Haffen Lamm

Valneva : FDA lifts age restriction on IXCHIQ

Valneva announced yesterday that the FDA has lifted its recommended pause on the use of IXCHIQ in individuals aged 60+, following updated safety data. This follows a similar decision by the EMA in July, which lifted temporary restrictions after a safety review. Despite regulatory clearance from bot

August 8, 2025 August 8, 2025 1 EN

Clément Genelot

Clément Genelot

Ahold Delhaize: navigating investments and FX headwinds well

Post-Q2, we have left our FY25-27 estimates broadly unchanged with a EUR38 PT. Ahold Delhaize continues to demonstrate its ability to balance growth investments and margin preservation while the USD headwind is already reflected in EPS expectations and the P/E multiple de-rating. At 12.7x P/E, valu

August 7, 2025 August 7, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN